Skip to content

Clinical trials

Completed Thyroid Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Status: Completed Country / region: United States Clear all

138 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20021
20034
20048
20058
200611
20076
20089
20096
20103
20117
20128
20133
20147
20158
20164
20177
20181
20208
20215
20225
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed138

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
Memorial Sloan Kettering Cancer Center9
Dana-Farber Cancer Institute4
Eisai Inc.4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Bayer3
Genzyme, a Sanofi Company3
Pfizer3
Stanford University3
Case Comprehensive Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms138
Thyroid Cancer, Papillary30
Breast Neoplasms29
Head and Neck Neoplasms27
Adenocarcinoma, Follicular24
Prostatic Neoplasms21
Carcinoma, Medullary20
Neoplasms20
Carcinoma, Non-Small-Cell Lung19
Lung Neoplasms19

Trials

Showing 1 to 25 of 138. Each trial links to its page on Pharma Observatory.

38 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.